Tegoprubart to be Used as Immunosuppressive Agent in Cohort C of Sernova’s Phase 1/2 Cell Pouch Bio-hybrid Organ Clinical Trial in Patients with Type 1 Diabetes ...

WALTHAM, MA, USA I July 9, 2025 I Sironax, a clinical-stage biotech company dedicated to the discovery and development of transformational therapies for ...